References
- WHO Coronavirus Disease (COVID-19) Dashboard: World Health Organization; 2021. Available from: https://covid19.who.int/?gclid = CjwKCAiAirb_BRBNEiwALHlnDzUZCpkqWlmb-5xmq0d0Z77zf_kFIDtAaayJHZhnN0gDX4TNxH6wEBoC2 × 8QAvD_BwE. Accessed: Jan 1, 2021.
- Chua GT, Xiong X, Choi EH, et al. COVID-19 in children across three Asian cosmopolitan regions. Emerg Microbes Infect. 2020;39(7):2588–2596. doi:https://doi.org/10.1080/22221751.2020.1846462
- Xiong X, Chua GT, Chi S, et al. A comparison between Chinese children infected with coronavirus disease-2019 and with severe acute respiratory syndrome 2003. J Pediatr. 2020;224:30–36.
- Lu Y, Li Y, Deng W, et al. Symptomatic infection is associated with prolonged duration of viral shedding in mild coronavirus disease 2019: a retrospective study of 110 children in Wuhan. Pediatr Infect Dis J. 2020;39(7):e95–e99. doi:https://doi.org/10.1097/INF.0000000000002729
- Wu H, Zhu H, Yuan C, et al. Clinical and immune features of hospitalized pediatric patients With coronavirus disease 2019 (COVID-19) in Wuhan China. JAMA Network Open. 2020;3(6):e2010895-e.
- Xu B, Fan C-Y, Wang A-L, et al. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China. J Infect. 2020;81(1):e51–e60.
- Zhao Q, Meng M, Kumar R, et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis. 2020;96:131–135.
- Wang F, Nie J, Wang H, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pnemonia. J Infect Dis. 2020;221(11):1762–1769.
- Zhou R, To KK-W, Wong Y-C, et al. Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses. Immunity. 2020;53(4):864–877.e5.
- To KK-W, Tsang OT-Y, Yip CC-Y, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020;71(15):841–843.
- Wong SCY, Tse H, Siu HK, et al. Posterior oropharyngeal saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71(11):2939–2946. doi:https://doi.org/10.1093/cid/ciaa797
- Azzi L, Carcano G, Gianfagna F, et al. Saliva is a reliable tool to detect SARS-CoV-2. Journal of Infection. 2020;81(1):e45–e50.
- Heald-Sargent T, Muller WJ, Zheng X, et al. Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to Moderate coronavirus disease 2019 (COVID-19). JAMA Pediatr. 2020;174(9):902–903.
- Han MS, Seong M-W, Kim N, et al. Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19, Seoul, South Korea. Emerg Infect Dis. 2020;26(10):2497–2499.
- To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565–574.
- Ding Y, Zhou L, Xia Y, et al. Reference values for peripheral blood lymphocyte subsets of healthy children in China. J Allergy Clin Immunol. 2018;142(3):970–973. e8.
- Chen P, Nirula A, Heller B, et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in Outpatients with covid-19. N Engl J Med. 2021;384(3):229–237. doi:https://doi.org/10.1056/NEJMoa2029849
- Yip CC-Y, Sridhar S, Cheng AK-W, et al. Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection. J Clin Virol. 2020;129:104476.
- Chan JF-W, Yip CC-Y, To KK-W, et al. Improved Molecular diagnosis of COVID-19 by the Novel, Highly Sensitive and specific COVID-19-RdRp/Hel Real-time reverse transcription-PCR assay validated <em>In Vitro</em> and with clinical specimens. J Clin Microbiol. 2020;58(5):e00310-20.
- Bryan A, Pepper G, Wener MH, et al. Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho. J Clin Microbiol. 2020;58(8):e00941–20.
- Zheng Y, Huang Z, Ying G, et al. Study of the lymphocyte change between COVID-19 and non-COVID-19 pneumonia cases suggesting other factors besides uncontrolled inflammation contributed to multi-organ injury. medRxiv. 2020: 2020.02.19.20024885. doi:https://doi.org/10.1101/2020.02.19.20024885
- Chong CY, Kam K-Q, Li J, et al. Saliva is not a useful diagnostic specimen in children with coronavirus disease 2019. Clin Infect Dis. 2020;ciaa1376. doi:https://doi.org/10.1093/cid/ciaa1376. [published online ahead of print, 2020 Sep 14].
- Wyllie AL, Fournier J, Casanovas-Massana A, et al. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. N Engl J Med. 2020;383(13):1283–1286. doi:https://doi.org/10.1056/NEJMc2016359
- Yonker LM, Neilan AM, Bartsch Y, et al. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses. J Pediatr. 2020;227:45–352. doi:https://doi.org/10.1016/j.jpeds.2020.08.037
- Harding H, Broom A, Broom J. Aerosol-generating procedures and infective risk to healthcare workers from SARS-CoV-2: the limits of the evidence. J Hosp Infect. 2020;105(4):717–725.
- Zhang W, Cheng W, Luo L, et al. Secondary Transmission of coronavirus disease from Presymptomatic Persons, China. Emerg Infect Dis. 2020;26(8):1924–1926.
- Long Q-X, Liu B-Z, Deng H-J, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845–848.
- Pujadas E, Chaudhry F, McBride R, et al. SARS-CoV-2 viral load predicts COVID-19 mortality. The Lancet Respiratory Medicine. 2020;8(9):e70.
- Liu L, Wei Q, Alvarez X, et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J Virol. 2011;85(8):4025–4030.
- Ponzio TA, Sanders JW. The salivary gland as a target for enhancing immunization response. Trop Dis Travel Med Vaccines. 2017;3(1):4.
- Zhang W, Li L, Liu J, et al. The characteristics and predictive role of lymphocyte subsets in COVID-19 patients. Int J Infect Dis. 2020;99:92–99.